Visiongain Report Claims there is Huge Potential within the $14bn Antidepressant and Anti-Anxiety Drugs Market - PRNewswire

Submitted by Anonymous (not verified) on Thu, 05/16/2019 - 09:00

Visiongain Report Claims there is Huge Potential within the $14bn Antidepressant and Anti-Anxiety Drugs Market  PRNewswireLONDON, May 16, 2019 /PRNewswire/ -- Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Atypical...